Medtronic plc. (MDT) Financials
MDT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-01-31 | 90.8 billion | 38.8 billion |
2023-10-31 | 90.1 billion | 38.4 billion |
2023-07-31 | 90.8 billion | 39.4 billion |
2023-04-30 | 90.9 billion | 39.3 billion |
MDT Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-01-31 | 2.1 billion | 84.0 million |
2023-10-31 | 200.0 million | 146.0 million |
2023-07-31 | 521.0 million | 73.0 million |
2023-04-30 | 2.1 billion | 75.0 million |
MDT Net Income
Date | Net Income |
---|---|
2024-01-31 | 1.3 billion |
2023-10-31 | 911.0 million |
2023-07-31 | 797.0 million |
2023-04-30 | 1.2 billion |
MDT Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-01-31 | 8.3 billion | - | 56.0 million |
2023-10-31 | 7.7 billion | - | 56.0 million |
2023-07-31 | 7.9 billion | 24.5 billion | 57.0 million |
2023-04-30 | 8.0 billion | 24.3 billion | 64.0 million |
MDT Shares Outstanding
MDT Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-01-31 | 346.0 million | 695.0 million | 2.7 billion | - |
2023-10-31 | 461.0 million | 698.0 million | 2.7 billion | - |
2023-07-31 | 354.0 million | 668.0 million | 2.6 billion | - |
2023-04-30 | 378.0 million | 640.0 million | 2.6 billion | - |
MDT Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-01-31 | 8.1 billion | 2.8 billion |
2023-10-31 | 8.0 billion | 2.8 billion |
2023-07-31 | 7.7 billion | 2.6 billion |
2023-04-30 | 8.5 billion | 3.0 billion |
MDT
List: Champions
Price: $80.38
Dividend Yield: 0.03%
Forward Dividend Yield: 3.40%
Payout Ratio: 89.61%
Dividend Per Share: 2.76 USD
Earnings Per Share: 3.15 USD
P/E Ratio: 27.14
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 4.3 million
Ebitda: 2.0 billionMarket Capitalization: 106.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: 7.40%
DGR5: 7.52%
DGR10: 9.08%
DGR20: 11.01%